P2Y12 Receptor

The P2Y12 receptor is an ADP-activated platelet receptor that plays a central role in platelet activation, thrombus formation, hemostasis, and thrombosis^[1][2]. Mechanistically, P2Y12 signaling amplifies platelet activation by supporting α_IIbβ₃ integrin activation and platelet aggregation through a phosphoinositide 3-kinase-dependent pathway^[3]. In thrombin-stimulated platelets, autocrine or added ADP stimulates P2Y12 receptors to enhance and prolong Ca²⁺ mobilization, with PI3Kβ, rather than PI3Kγ, driving prolonged Ca²⁺ response, procoagulant activity, and coagulation^[4]. In disease-related settings, P2Y12 inhibition supports antithrombotic therapy in coronary artery disease, acute coronary syndrome, myocardial infarction, and percutaneous coronary intervention^[5][6]. Compared with related platelet activation pathways, P2Y12 can generate P2Y1-independent inside-out signaling, while PAR-1 and PAR-4 platelet responsiveness may persist despite adequate P2Y12 inhibition^[3][7]. For experimental and translational applications, clopidogrel, prasugrel, ticagrelor, cangrelor, and novel reversible antagonists provide tools to study ADP-induced platelet aggregation, receptor specificity, pharmacodynamic variability, and thrombotic disease models^[5][8][9].